Medtech parigina che sviluppa Colovac, bypass endoluminale per evitare le stomie temporanee nella chirurgia colorettale.
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Series C SafeHeal extended its Series C by €10 million led by Asabys Partners, bringing total funding to €97.5 million, for the US trials of Colovac. | $11.6M |